Cargando…

Combat Diabetic Nephropathy: From Pathogenesis to Treatment

Detalles Bibliográficos
Autores principales:	Gohda, Tomohito, Mima, Akira, Moon, Ju-Young, Kanasaki, Keizo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2014
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3972827/ https://www.ncbi.nlm.nih.gov/pubmed/24741570 http://dx.doi.org/10.1155/2014/207140

Ejemplares similares

Pathogenesis and Novel Treatment from the Mouse Model of Type 2 Diabetic Nephropathy
por: Furukawa, Masako, et al.
Publicado: (2013)

Combating Kidney Fibrosis
por: Kanasaki, Keizo, et al.
Publicado: (2014)

Editorial: Combating Diabetes and Diabetic Kidney Disease
por: Srivastava, Swayam Prakash, et al.
Publicado: (2021)

Lipid mediators in diabetic nephropathy
por: Srivastava, Swayam Prakash, et al.
Publicado: (2014)

The Role of Ubiquitination and Sumoylation in Diabetic Nephropathy
por: Gao, Chenlin, et al.
Publicado: (2014)

Epigenetic regulation of core genes linking to diabetic nephropathy progression: Lesson from FinnDiane type 1 diabetes study
por: Makino, Hirofumi, et al.
Publicado: (2023)

Role of Mindin in Diabetic Nephropathy
por: Murakoshi, Maki, et al.
Publicado: (2011)

Diabetic nephropathy: the role of inflammation in fibroblast activation and kidney fibrosis
por: Kanasaki, Keizo, et al.
Publicado: (2013)

MicroRNAs in Kidney Fibrosis and Diabetic Nephropathy: Roles on EMT and EndMT
por: Srivastava, Swayam Prakash, et al.
Publicado: (2013)

Sirtuins and renal diseases: relationship with aging and diabetic nephropathy
por: Kitada, Munehiro, et al.
Publicado: (2012)

Autophagy as a Therapeutic Target in Diabetic Nephropathy
por: Tanaka, Yuki, et al.
Publicado: (2012)

The Relevance of the Renin-Angiotensin System in the Development of Drugs to Combat Preeclampsia
por: Ueki, Norikazu, et al.
Publicado: (2015)

N-acetyl-seryl-aspartyl-lysyl-proline: a valuable endogenous anti-fibrotic peptide for combating kidney fibrosis in diabetes
por: Kanasaki, Keizo, et al.
Publicado: (2014)

Epigenetics in the pathogenesis of diabetic nephropathy: Epigenetics in the pathogenesis of diabetic nephropathy
por: Li, Xue, et al.
Publicado: (2021)

Diabetic Nephropathy: From Pathophysiology to Treatment
por: Shen, Ziyan, et al.
Publicado: (2017)

Loss of endothelial glucocorticoid receptor accelerates diabetic nephropathy
por: Srivastava, Swayam Prakash, et al.
Publicado: (2021)

Pathogenesis of diabetic nephropathy
por: Cao, Zemin, et al.
Publicado: (2011)

Inflammation and Oxidative Stress in Diabetic Nephropathy: New Insights on Its Inhibition as New Therapeutic Targets
por: Mima, Akira
Publicado: (2013)

Sodium-Glucose Cotransporter-2 Inhibitors—Miracle Drugs for the Treatment of Chronic Kidney Disease Irrespective of the Diabetes Status: Lessons from the Dedicated Kidney Disease-Focused CREDENCE and DAPA-CKD Trials
por: Gohda, Tomohito, et al.
Publicado: (2022)

Diabetic Nephropathy: Challenges in Pathogenesis, Diagnosis, and Treatment
por: Samsu, Nur
Publicado: (2021)

Diabetic Retinopathy: From Pathogenesis to Treatment
por: Chakrabarti, Subrata
Publicado: (2007)

Treatment of Hepatitis B Virus-Associated Membranous Nephropathy: Lamivudine Era versus Post-Lamivudine Era
por: Moon, Ju-Young, et al.
Publicado: (2012)

A low-protein diet exerts a beneficial effect on diabetic status and prevents diabetic nephropathy in Wistar fatty rats, an animal model of type 2 diabetes and obesity
por: Kitada, Munehiro, et al.
Publicado: (2018)

Dietary Restriction Ameliorates Diabetic Nephropathy through Anti-Inflammatory Effects and Regulation of the Autophagy via Restoration of Sirt1 in Diabetic Wistar Fatty (fa/fa) Rats: A Model of Type 2 Diabetes
por: Kitada, Munehiro, et al.
Publicado: (2011)

Microinflammation in the pathogenesis of diabetic nephropathy
por: Shikata, Kenichi, et al.
Publicado: (2013)

Inflammatory Regulation in Diabetes and Metabolic Dysfunction
por: Zhong, Jixin, et al.
Publicado: (2017)

N‐acetyl‐seryl‐aspartyl‐lysyl‐proline is a valuable endogenous antifibrotic peptide for kidney fibrosis in diabetes: An update and translational aspects
por: Kanasaki, Keizo
Publicado: (2020)

The Role of Autophagy in the Pathogenesis of Diabetic Nephropathy
por: Yamahara, Kosuke, et al.
Publicado: (2013)

Special Issue: New Insights into the Pathogenesis and Therapies of IgA Nephropathy
por: Suzuki, Hitoshi, et al.
Publicado: (2022)

Special Issue “Diabetic Nephropathy: Diagnosis, Prevention and Treatment”
por: Ruiz-Ortega, Marta, et al.
Publicado: (2020)

Antiphospholipid Syndrome Nephropathy: From Pathogenesis to Treatment
por: Tektonidou, Maria G.
Publicado: (2018)

Circulating TNF Receptors 1 and 2 Are Associated with the Severity of Renal Interstitial Fibrosis in IgA Nephropathy
por: Sonoda, Yuji, et al.
Publicado: (2015)

Editorial: Receptor Biology and Cell Signaling in Diabetes
por: Srivastava, Swayam Prakash, et al.
Publicado: (2022)

Classical molecule in diabetic kidney hypertrophy is linked to defects in self‐eating through fine‐tuning
por: Takagaki, Yuta, et al.
Publicado: (2021)

Editorial: Receptor biology and cell signaling in diabetes: volume II
por: Srivastava, Swayam Prakash, et al.
Publicado: (2023)

Circulating Tumor Necrosis Factor Receptors: A Potential Biomarker for the Progression of Diabetic Kidney Disease
por: Murakoshi, Maki, et al.
Publicado: (2020)

A glimpse of diabetic nephropathy
por: Khoshjou, Farhad
Publicado: (2016)

Dipeptidyl peptidase-4 and kidney fibrosis in diabetes
por: Shi, Sen, et al.
Publicado: (2016)

Complexity of diabetic nephropathy pathogenesis and design of investigations
por: Tavafi, Majid
Publicado: (2013)

The Role of MicroRNAs in the Pathogenesis of Diabetic Nephropathy
por: Tang, Jian, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_cvp16bflcol5cdugr8l0tpu6io